Amplification with hearing aids for patients with tinnitus and co‐existing hearing loss

摘要: Background Tinnitus is described as the perception of sound or noise in absence real acoustic stimulation. In current a cure for tinnitus, clinical management typically focuses on reducing effects co-morbid symptoms such distress hearing loss. Hearing loss commonly with tinnitus and so logic implies that amplification external sounds by aids will reduce associated it. Objectives To assess specifically terms benefit patients co-existing loss. Search methods We searched Cochrane Ear, Nose Throat Disorders Group Trials Register; Central Register Controlled (CENTRAL); PubMed; EMBASE; CINAHL; Web Science; Cambridge Scientific Abstracts; ICTRP additional sources published unpublished trials. The date search was 19 August 2013. Selection criteria Randomised controlled trials non-randomised recruiting adults subjective some degree loss, where intervention involves this compared to interventions involving other medical devices, forms standard complementary therapy, combinations therapies, no placebo interventions. Data collection analysis Three authors independently screened all selected abstracts. Two extracted data assessed those potentially suitable studies risk bias. For meeting inclusion criteria, we used mean difference (MD) compare controls. Main results One randomised trial (91 participants) included review. We judged have low bias method randomisation outcome reporting, an unclear criteria. No our criteria were identified. study measured change severity (primary measure interest) using questionnaire measure, loudness (secondary visual analogue scale. Other secondary measures interest, namely psychoacoustic characteristics self reported anxiety, depression quality life, neurophysiological measures, not investigated study. aid use generator use. estimated effect Tinnitus Handicap Inventory score compatible benefits both generators but found between two alternative treatments (MD -0.90, 95% confidence interval (CI) -7.92 6.12) (100-point scale); moderate evidence. negative adverse events reported. Authors' conclusions The evidence base prescription limited. To be useful, future should make appropriate blinding consistent their measures. Whilst are sometimes prescribed part management, there currently support refute more routine tinnitus.